Study on the Treatment of Double/Triple-hit DLBCL With Chidamide and Lisaftoclax in Combination With Pola-R-CHP

NCT07552324 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

28

Enrollment

OTHER

Sponsor class

Conditions

DHL
THL
DLBCL - Diffuse Large B Cell Lymphoma

Interventions

DRUG: CL-Pola-R-CHP

Sponsor

Ruijin Hospital